Keros Therapeutics, Inc. (NASDAQ:KROS) IPO

Keros Therapeutics, Inc.

IPO

Priced at US$16.00 a share on Apr 7, 2020.

Price
US$16.00 a share
Shares offered
6,000,000 shares of common stock
Offering size
US$96 million
Underwriters' option
Up to 900,000 more shares
Underwriters
Jefferies, SVB Leerink, Piper Sandler, H.C. Wainwright & Co. · In the order on the cover
Shares delivered
On or about Apr 13, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceJan 21, 2020
Filed publiclyMar 16, 2020
Amended twiceNewest Apr 7, 2020
Shares registered with an exchangeApr 3, 2020
Declared effective by the SECApr 7, 2020
Final prospectus, with the priceApr 8, 2020

From the cover of the final prospectus (424B4) filed Apr 8, 2020